Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hanafin, Patrick O.
14  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Proof‐of‐concept for incorporating mechanistic insights fro..:

Hanafin, Patrick O ; Abdul Rahim, Nusaibah ; Sharma, Rajnikant...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014067/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

A Systems-Based Analysis of Mono- and Combination Therapy f..:

Luterbach, Courtney L ; Qiu, Hongqiang ; Hanafin, Patrick O...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578421/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Assessing the predictive performance of population pharmaco..:

Hanafin, Patrick O ; Nation, Roger L ; Scheetz, Marc H...
CPT: pharmacometrics & systems pharmacology. New York. Vol. 10 (2021), p. 1525–1537.  , 2021
Link: http://hdl.handle.net/10..
 
?
4

Insights Into Patient Variability During Ivacaftor-Lumacaft..:

Hanafin, Patrick O ; Sermet-Gaudelus, Isabelle ; Griese, Matthias...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365608/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

A mechanism‐based pharmacokinetic model of remdesivir lever..:

Hanafin, Patrick O ; Jermain, Brian ; Hickey, Anthony J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894405/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

Assessing the predictive performance of population pharmaco..:

Hanafin, Patrick O ; Nation, Roger L ; Scheetz, Marc H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674003/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

Evaluation Strategies for Triple‐Drug Combinations against ..:

Garcia, Estefany ; Diep, John K ; Sharma, Rajnikant...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048493/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

Development of a Minimal Physiologically-Based Pharmacokine..:

Jermain, Brian ; Hanafin, Patrick O ; Cao, Yanguang...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.xphs.2020.08.024.  ,
Link: http://hdl.handle.net/11..
 
?
9

Proof‐of‐concept for incorporating mechanistic insights fro..:

Patrick O. Hanafin ; Nusaibah Abdul Rahim ; Rajnikant Sharma...
https://doi.org/10.1002/psp4.12923.  , 2023
Link: https://doi.org/10.1002/..
 
?
10

A mechanism‐based pharmacokinetic model of remdesivir lever..:

Patrick O. Hanafin ; Brian Jermain ; Anthony J. Hickey...
https://doi.org/10.1002/psp4.12584.  , 2021
Link: https://doi.org/10.1002/..
 
?
11

DataSheet1_Insights Into Patient Variability During Ivacaft..:

Patrick O. Hanafin ; Isabelle Sermet-Gaudelus ; Matthias Griese...
doi:10.3389/fphar.2021.577263.s001.  , 2021
Link: https://doi.org/10.3389/..
 
?
12

Insights Into Patient Variability During Ivacaftor-Lumacaft..:

Patrick O. Hanafin ; Isabelle Sermet-Gaudelus ; Matthias Griese...
https://www.frontiersin.org/articles/10.3389/fphar.2021.577263/full.  , 2021
Link: https://doi.org/10.3389/..
 
?
13

Assessing the predictive performance of population pharmaco..:

Patrick O. Hanafin ; Roger L. Nation ; Marc H. Scheetz...
https://doi.org/10.1002/psp4.12720.  , 2021
Link: https://doi.org/10.1002/..
 
?
14

DataSheet1_Insights Into Patient Variability During Ivacaft..:

Patrick O. Hanafin (11216136) ; Isabelle Sermet-Gaudelus (173646) ; Matthias Griese (46185)...
https://figshare.com/articles/dataset/DataSheet1_Insights_Into_Patient_Variability_During_Ivacaftor-Lumacaftor_Therapy_in_Cystic_Fibrosis_pdf/15089232.  , 2021
Link: https://doi.org/10.3389/..
 
1-14